May 13, 2013

Jerry Rhodes, chief operating officer for CRC Health Group, will receive the Nyswander-Dole Award for his outstanding contributions to the opioid treatment field in the fall at the American Association for the Treatment of Opioid Dependence (AATOD) Conference in Philadelphia. “We congratulate Jerry on this fantastic and well-deserved achievement that validates a career-long dedication to the treatment field,” said CRC Health Group CEO R. Andrew Eckert. “His championing of medication-assisted treatment as one of the most effective means for overcoming opiate addiction has saved thousands of lives. He is a true leader in the field and a treasured member of the CRC Health team.” The Nyswander-Dole Award, named for the founders of methadone treatment, was first presented in 1983 to recognize extraordinary work and service in the opioid treatment field. The award recipients are selected by peers from each region. Rhodes was selected by his peers within the Pennsylvania Association for the Treatment of Opioid Dependence (PATOD). Prior to joining CRC in 2003, he was the chief executive officer for Comprehensive Addictions Programs Inc. (CAP). “I am surprised and humbled by this award,” said Rhodes. “Twenty-three million people need but do not receive substance abuse treatment, and I am proud that CRC is leading the effort to help them. The treatment field has made great strides, but we have a lot more work to do.” The award will be presented by A. Thomas McLellan, Ph.D., CEO and co-founder of the Treatment Research Institute (TRI), and current Clinical Advisory Board member for CRC. •